Better recovery for lung
cancer 2025
New Year New You ’ distributed with The Guardian 4th January 2025
The article in text format:
Better recovery for lung cancer 2025
Recent advances in lung cancer treatment are bringing new hope to patients, with exciting developments in immunotherapy, targeted therapies, and antibody-drug conjugates (ADCs).
Immunotherapy harnesses the body’s immune system to recognise and fight cancer cells, offering a less invasive alternative to traditional chemotherapy.
Targeted therapies focus on specific genes or proteins that allow cancer cells to grow, making treatments more effective and with fewer side effects. ADCs, a promising option, deliver cancer-fighting drugs directly to tumour cells, minimising harm to healthy cells.
Experimental cell therapies and cancer vaccines are also being explored as new ways to empower the body against lung cancer, showing remarkable potential in trials. In the hands of an experienced lung oncologist and a dedicated multidisciplinary team, these therapies could be life-changing.
Together, these advanced treatments could greatly improve patient outcomes, offering a brighter future and an improved quality of life for those facing lung cancer.